Financial Sector (Collection of Data) (reporting standard) determination No. 2 of 2024 (Cth)

Financial Sector (Collection of Data) (reporting standard) determination No. 2 of 2024

Reporting Standard HRS 603.0 Statistical Data on Medical Devices or Human Tissue Products Benefits

Financial Sector (Collection of Data) Act 2001

I, Andrew Robertson, delegate of APRA, under paragraph 13(1)(a) of the Financial Sector (Collection of Data) Act 2001 (the Act) and subsection 33(3) of the Acts Interpretation Act 1901:

(a) revoke Financial Sector (Collection of Data) (reporting standard) determination No. 33 of 2015, including Reporting Standard HRS 603.0 Statistical Data on Prosthetic Benefits made under that Determination; and

(b) determine Reporting Standard HRS 603.0 Statistical Data on Medical Devices or Human Tissue Products Benefits, in the form set out in the Schedule, which applies to the financial sector entities to the extent provided in paragraph 3 of the reporting standard.

Under section 15 of the Act, I declare that the reporting standard shall begin to apply to those financial sector entities, and the revoked reporting standard shall cease to apply, at the start of the day after the instrument is registered on the Federal Register of Legislation.

This instrument commences at the start of the day after the day that the instrument is registered on the Federal Register of Legislation.

Dated: 1 February 2024

Andrew Robertson General Manager – Chief Data Officer

Technology and Data Division

Interpretation

In this Determination:

APRA means the Australian Prudential Regulation Authority.

Federal Register of Legislation means the register established under section 15A of the Legislation Act 2003.

financial sector entity has the meaning given by section 5 of the Act.

Schedule

Reporting Standard HRS 603.0 Statistical Data on Medical Devices or Human Tissue Products Benefits comprises the document commencing on the following page.